Vonjo

A new JAK inhibitor earns FDA nod in myelofibrosis, setting up a fight with Incyte, Bristol Myers
Endpoints
Tue, 03/1/22 - 10:35 am
CTI BioPharma
JAK inhibitors
Vonjo
pacritinib
FDA
myelofibrosis
Incyte
Bristol Myers Squibb